C
MannKind Corporation MNKD
$5.59 $0.000.00% NASDAQ
Recommendation
Prev Close
$5.59
Volume
3,394,330
Avg Vol (90D)
4,340,500
Market Cap
$1.72B
Dividend & Yield
--
52-Week Range
$3.38 - $7.07
P/E (TTM)
57.87
EPS (TTM)
$0.10
My Lists My Alerts
Access our Premium Ratings
Get Access
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
MannKind's ReadyFlow Autoinjector: A Game Changer For Heart Failure Patients
12/3/2025 - SeekingAlpha
MannKind's ReadyFlow Autoinjector: A Game Changer For Heart Failure Patients
12/3/2025 - Seeking Alpha - Long Ideas
MannKind (MNKD, $5.59) price may drop as it broke higher Bollinger Band on Dec 02, 2025
12/3/2025 - Tickeron - Stocks
Is MannKind a Hidden Opportunity After Recent Share Price Slide?
12/3/2025 - Simply Wall St
MannKind (MNKD, $5.43) price moved above its 50-day Moving Average on December 01, 2025
12/2/2025 - Tickeron - Stocks
MannKind (MNKD) Awaits FDA Decision on Furoscix Autoinjector
12/1/2025 - GuruFocus
MannKind's Furoscix Autoinjector under FDA review for expanded label
12/1/2025 - Seeking Alpha - Healthcare
MannKind (MNKD) Awaits FDA Decision on FUROSCIX ReadyFlow Autoinjector
12/1/2025 - GuruFocus
MannKind says FDA accepts for review its sNDA of of FUROSCIX ReadyFlow
12/1/2025 - The Fly
MannKind Announces U.S. FDA Accepts for Review its Supplemental New Drug Application (sNDA) of FUROSCIX ReadyFlow Autoinjector for the Treatment of Edema in Adults with Chronic Heart Failure or Chronic Kidney Disease
12/1/2025 - Globe Newswire
MannKind (MNKD) Is Up 6.4% After Wave of Analyst Upgrades Despite MNKD-101 Discontinuation Has The Bull Case Changed?
11/29/2025 - Simply Wall St
MannKind (MNKD, $5.35) price exceeded its 50-day Moving Average on November 28, 2025
11/29/2025 - Tickeron - Stocks
Assessing MannKind (MNKD) Valuation as Recent Momentum Renews Investor Interest
11/28/2025 - Simply Wall St
MannKind (MNKD, $5.38) Stochastic Oscillator left the overbought zone on November 26, 2025
11/27/2025 - Tickeron - Stocks
MannKind (MNKD, $5.38) price moved above its 50-day Moving Average on November 26, 2025
11/27/2025 - Tickeron - Stocks
MannKind (MNKD, $5.38) Moving Average Convergence Divergence (MACD) Histogram turned positive on November 26, 2025
11/27/2025 - Tickeron - Stocks
MannKind Corporation $MNKD Shares Purchased by Intech Investment Management LLC
11/27/2025 - MarketBeat
MannKind (MNKD, $5.36) entered Uptrend as Momentum indicator ascends above 0 level on Nov 25, 2025
11/26/2025 - Tickeron - Stocks
MannKind (MNKD, $5.36) Stochastic Oscillator left the oversold zone on November 25, 2025
11/26/2025 - Tickeron - Stocks
MannKind (NASDAQ:MNKD) Now Covered by Analysts at Truist Financial
11/25/2025 - MarketBeat
MannKind (NASDAQ:MNKD) Now Covered by Analysts at Truist Financial
11/24/2025 - Ticker Report
MannKind initiated with bullish view at Truist, here's why
11/24/2025 - The Fly
MannKind Corporation (NASDAQ:MNKD) Given Average Recommendation of "Moderate Buy" by Brokerages
11/21/2025 - MarketBeat
MannKind Corporation $MNKD Shares Purchased by TSP Capital Management Group LLC
11/20/2025 - MarketBeat
What MannKind (MNKD)'s Phase 3 Trial Discontinuation Means for Pipeline Prospects and Shareholder Expectations
11/19/2025 - Simply Wall St
Income Statement
Total Revenue (TTM)
$313.79M
EBITDA (TTM)
$84.72M
EBIT (TTM)
$76.30M
Net Income (TTM)
$29.23M
Balance Sheet
Total Assets (Q)
$494.64M
Total Debt (Q)
$225.43M
Total Liabilities (Q)
$539.19M
Book Value Per Share (Q)
-$0.1451
Cash Flow
Cash from Operations (TTM)
$48.86M
Cash from Investing (TTM)
$35.38M
Cash from Financing (TTM)
-$19.21M
Net Change in Cash (TTM)
$65.03M
Filings
Filing Date
Wednesday, November 5, 2025
Period Date
Tuesday, September 30, 2025
Next Filing
Week of Feb 23 and 27 (est)
Price History
Loading...
Beta
0.74
7-Day Total Return
11.13%
30-Day Total Return
1.45%
60-Day Total Return
1.45%
90-Day Total Return
41.16%
Year to Date Total Return
-15.30%
1-Year Total Return
-16.69%
2-Year Total Return
49.07%
3-Year Total Return
21.26%
5-Year Total Return
96.14%
52-week Low
Aug 11, 2025 - $3.38
52-week High
Dec 20, 2024 - $7.07
Valuation
Market Cap
$1.72B - Small Cap
Enterprise Value
$1.68B
Price/Sales (TTM)
5.55
Price/Book (Q)
-38.53
Dividends and Shares
Shares Outstanding
311.64
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
www.mannkindcorp.com
Phone Number
818 661 5000
Address
1 Casper Street
Danbury, CT 06810
Country
United States
Year Founded
1991
Business Description
Sector
Health Care
Industry
Pharmaceuticals, Biotechnology and Life Sciences
MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of therapeutic products and services for endocrine and orphan lung diseases in the United... more
NASDAQ 12/03/2025 4:00PM Eastern Quotes delayed